PrimeX News

Broker News

US Dollar Price Forecast: DXY Holds $98.50 After Hot CPI — Can GBP/USD and EUR/USD Hold Support?
Thu, 14 May 2026 08:46:36 GMT
First Light News: Beijing, Warsh, and Westminster
Thu, 14 May 2026 08:45:51 GMT
Gold (XAUUSD) & Silver Price Forecast: Ceasefire Holds — Gold Defends $4,697, Silver Surges to $87 as CPI Hits Rate Cuts?
Thu, 14 May 2026 08:09:53 GMT
Natural Gas and Oil Forecast: Ceasefire Holds — WTI Reclaims $101, Brent Defends $106 — NatGas Tests $2.89?
Thu, 14 May 2026 08:03:12 GMT
Oil Price Forecast: Trump-Xi Talks and Hormuz Risk Keep Brent Above $100
Thu, 14 May 2026 04:48:55 GMT
Nikkei 225 Forecast: Trump-Xi Trade Hopes and Tech Rally Point to 65,000
Thu, 14 May 2026 03:00:38 GMT

ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 30 Apr 2026 13:08:34 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Mon, 13 Apr 2026 16:16:44 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 26 Mar 2026 21:25:31 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Mon, 16 Mar 2026 13:30:15 GMT
Jobs Miss and Oil Spike Signal Stagflation Risk for U.S. Economy
Fri, 20 Mar 2026 20:24:14 GMT

How Renko Charts Filter Market Noise & Improve Trend Analysis
Sun, 10 May 2026 14:02:44 GMT
Getting an Edge From Factor Investing
Sat, 09 May 2026 10:43:54 GMT
US Sector Rotation Strategy: Using the Business Cycle & RRG Charts to Find Market Leaders
Sun, 03 May 2026 16:49:46 GMT
Silver (XAG) Forecast: Weak Below 50-Day MA, Silver Analysis Signals More Downside
Tue, 21 Apr 2026 17:29:23 GMT
What Are Leveraged and Inverse ETFs? Risks, Rewards, and Key Strategies
Mon, 23 Mar 2026 23:55:30 GMT
Bollinger Bands Trading Strategies: How to Read Volatility, Identify Market Regimes, and Trade with a Statistical Edge
Fri, 13 Mar 2026 22:59:16 GMT

Advertisement

Advertisement

ALLO

Allogene Therapeutics, Inc. Common Stock

2.33

USD

Sponsored

+0.03

+1.30%

May 13, 16:00 UTC -4

Closed

exchange

Pre-Market

2.31

-0.02

-0.77%

ALLO News & Forecasts

featured

Allogene Therapeutics Q1 Earnings Call Highlights

featured

Zacks Investment Research

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

featured

Allogene Therapeutics, Inc. (ALLO) Discusses Interim Futility Analysis from Pivotal Phase II ALPHA 3 Trial in First-Line Consolidation Large B-Cell Lymphoma Transcript

featured

Allogene: Early ALPHA3 Data Suggests Potential Paradigm Shift For Cema-Cel In LBCL

featured

Allogene Therapeutics, Inc. (ALLO) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript

Advertisement

Advertisement

Advertisement